PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för naltrexone hydrochloride. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

21 hits

Bibliografisk träff 2017-01-01

Release Characteristics In Vitro and In Vivo of In Situ Gels for a Novel Peptide Compared with Low-Molecular-Weight Hydrophilic Drug.

Zhang G, Hu J, Meng Q, Wang T, Yang X, Gao L, Quan D.

Curr Drug Deliv · comparative study; journal article · DOI 10.2174/1567201813666160720105242

Bibliografisk träff 2016-10-01

Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.

Garbutt JC, Kampov-Polevoy AB, Kalka-Juhl LS, Gallop RJ.

JAMA Psychiatry · randomized controlled trial; journal article · DOI 10.1001/jamapsychiatry.2016.2157

Bibliografisk träff 2016-08-12

Lithium attenuated the behavioral despair induced by acute neurogenic stress through blockade of opioid receptors in mice.

Khaloo P, Sadeghi B, Ostadhadi S, Norouzi-Javidan A, Haj-Mirzaian A, Zolfagharie S, Dehpour AR.

Biomed Pharmacother · journal article · DOI 10.1016/j.biopha.2016.08.015

Bibliografisk träff 2016-05-21

Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.

Backonja M, Webster LR, Setnik B, Bass A, Sommerville KW, Matschke K, Malhotra BK, Wolfram G.

Am J Drug Alcohol Abuse · randomized controlled trial; journal article · DOI 10.3109/00952990.2016.1167215

Bibliografisk träff 2016-01-26

Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trials.

Setnik B, Pixton GC, Webster LR.

Curr Med Res Opin · research support, non-u.s. gov't; journal article · DOI 10.1185/03007995.2015.1131153

Bibliografisk träff 2015-12-28

A stability-indicating HPLC method for simultaneous determination of morphine and naltrexone.

Jafari-Nodoushan M, Barzin J, Mobedi H.

J Chromatogr B Analyt Technol Biomed Life Sci · journal article · DOI 10.1016/j.jchromb.2015.12.048

Bibliografisk träff 2015-08-18

Cirrhosis-induced morphological changes in the retina: possible role of endogenous opioid.

Algazo MA, Amiri-Ghashlaghi S, Delfan B, Hassanzadeh G, Sabbagh-Ziarani F, Jazaeri F, Dehpour AR.

Int J Ophthalmol · research-article; journal article · DOI 10.3980/j.issn.2222-3959.2015.04.07

Bibliografisk träff 2015-07-08

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide.

Setnik B, Roland CL, Sommerville KW, Pixton GC, Berke R, Calkins A, Goli V.

J Pain Res · research-article; journal article · DOI 10.2147/jpr.s82395

Bibliografisk träff 2015-03-01

The use of thiafentanil oxalate and azaperone for reversible immobilisation of African buffalo (Syncerus caffer) within a nature reserve - Short communication.

Szabó Z, Venter DJ, Luyt Edu C, Raath C.

Acta Vet Hung · journal article · DOI 10.1556/avet.2015.002

Bibliografisk träff 2015-01-22

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.

Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.

Clin Pharmacol Drug Dev · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1002/cpdd.177

Bibliografisk träff 2014-11-04

Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies.

Abdelkader H, Pierscionek B, Alany RG.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2014.10.069

Bibliografisk träff 2014-02-01

Hydrogels composed of cyclodextrin inclusion complexes with PLGA-PEG-PLGA triblock copolymers as drug delivery systems.

Khodaverdi E, Mirzazadeh Tekie FS, Hadizadeh F, Esmaeel H, Mohajeri SA, Sajadi Tabassi SA, Zohuri G.

AAPS PharmSciTech · research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12249-013-0051-1

Bibliografisk träff 2013-09-08

DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patients.

Streel E, Chenut C, Papageorgiou C, Verbanck P.

Addict Behav · journal article · DOI 10.1016/j.addbeh.2013.08.031

Bibliografisk träff 2013-06-07

Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.

Setnik B, Sommerville K, Goli V, Han L, Webster L.

Pain Med · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1111/pme.12148

Bibliografisk träff 2012-11-27

Biodegradable In Situ Gel-Forming Controlled Drug Delivery System Based on Thermosensitive Poly(ε-caprolactone)-Poly(ethylene glycol)-Poly(ε-caprolactone) Hydrogel.

Khodaverdi E, Golmohammadian A, Mohajeri SA, Zohuri G, Mirzazadeh Tekie FS, Hadizadeh F.

ISRN Pharm · research-article; journal article · DOI 10.5402/2012/976879

Bibliografisk träff 2012-07-03

Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation.

Sun L, Wang T, Gao L, Quan D, Feng D.

Pharm Dev Technol · journal article · DOI 10.3109/10837450.2012.700934

Bibliografisk träff 2012-07-01

Advantages of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules in pain management.

Kapoor S.

J Opioid Manag · letter; comment · DOI 10.5055/jom.2012.0117

Bibliografisk träff 2012-05-14

Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.

Abdelkader H, Wu Z, Al-Kassas R, Alany RG.

Int J Pharm · comparative study; journal article · DOI 10.1016/j.ijpharm.2012.05.011

Bibliografisk träff 2012-04-18

Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA.

Khodaverdi E, Tekie FS, Mohajeri SA, Ganji F, Zohuri G, Hadizadeh F.

AAPS PharmSciTech · research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12249-012-9781-8

Bibliografisk träff 2012-03-01

Safety of EMBEda (morphine sulfate and naltrexone hydrochloride) extended-release capsules: review of postmarketing adverse events during the first year.

Badalamenti VC, Buckley JW, Smith ET.

J Opioid Manag · research support, non-u.s. gov't; journal article · DOI 10.5055/jom.2012.0104

Bibliografisk träff 2010-10-14

Food effects on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules.

Johnson F, Ciric S, Boudriau S, Swearingen D, Stauffer J.

Adv Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/s12325-010-0074-x